
Market Midday: Stocks Sell Off, Markets All Down More Than 1%, US Businesses Want Tariff Refunds 2/23/26
CNBC Business News Update
00:00
Novo Nordisk drug trial falls short of Lilly
Reporters discuss trial results showing Novo's obesity drug underperformed versus Eli Lilly's treatment.
Play episode from 02:58
Transcript


